₹ 667.15
-7.15 (-1.06%)
A
Aarti Pharma Labs
₹ 667.15
AARTIPHARM Fundamentals
Company Valuation
Market Cap (₹ Cr.)
6,048
PE Ratio
35.00
PB Ratio
2.88
Dividend Yield
0.22%
ROE
13.69%
ROCE
17.23%
Book Value (₹)
234.30
Face Value (₹)
5.00
Analyse AARTIPHARM with 12+ custom fundamentals and financial ratios.
Share Holding Pattern
| Held By | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|
| Promoters | 43.72% | 42.88% | 43.10% | 43.08% | 42.86% |
| Domestic Institutional Investors (DII) | 7.80% | 6.96% | 7.66% | 7.41% | 7.22% |
| Foreign Institutional Investors (FII) | 7.35% | 8.02% | 7.68% | 8.39% | 8.17% |
| Public Investors | 34.43% | 35.39% | 34.85% | 34.29% | 34.39% |
| Government | 0.01% | 0.01% | 0.01% | 0.01% | 0.01% |
Promoters
Domestic Institutional Investors (DII)
Foreign Institutional Investors (FII)
Public Investors
Government
AARTIPHARM Investment Returns
Short Term
1 Week
1 Month
3 Months
6 Months
9 Months
Long Term
1 Year
2 Years
3 Years
4 Years
5 Years
- In Short Term
- In Long term
1 Week
1 Month
3 Months
6 Months
9 Months
Create Wealth in Longterm with Weekly and Monthly SIP in Stocks.
Stock & Sector Information
Sector
Healthcare
Sub Sector
Pharmaceuticals
Company Classification
Microcap
BSE Scrip Code
543748
NSE Scrip Name
AARTIPHARM
ISIN
INE0LRU01027



